Vero Diagnostics Revenue and Competitors

Vero Diagnostics is a state-of-the-art clinical laboratory that incorporates the latest technology and methods to provide comprehensive diagnostic testing, including, urine and oral fluid drug monitoring, pathogen detection, Pharmacogenomics (PGx) testing, and blood testing. Vero Diagnostics has pioneered technology that allows us to analyze specimens in half the time of standard laboratories without sacrificing the clinical compliance of our science or the quality of service to our clients. Advanced automation, in conjunction with our laboratory information management system, gives us a “one-touch” methodology, allowing us to perform testing using lower sample volumes which minimizes the possibility of sample error. Vero Diagnostics are the first in its class to offer Bennett Polypharmacy Profile (BPP). The Bennett Polypharmacy Profile (BPP) is the only objective tool available to identify what medications you are actually taking. Simple Urinalysis that screens for the most commonly prescribed Diabetic, Cardiovascular, Blood Pressure and Over-the Counter Medications. Our integrated laboratory information and automation system is state of the art, which provides: Highly robust information management, enabling multiple tiers of data to facilitate integrated analytical reporting for the patient, provider and payor. Automated notification allowing us to provide tracking of specimen status in real-time, provider notifications, stat/critical values messaging, and presumptive/confirmatory reports with consistent vs inconsistent data reporting. As a CLIA registered laboratory, Vero Diagnostics compiles with the regulatory requirement and standards established by the Centers for Medicare & Medicaid Services (CMS) agency of the Federal government. Vero Diagnostics is currently accredited to accept specimens from many U.S. states. We are currently applying to several more highly regulated states for additional accreditations.